Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1b)
Condition(s):Decompensated CirrhosisLast Updated:August 9, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Decompensated CirrhosisLast Updated:August 9, 2023Not yet recruiting
Condition(s):Multiple SclerosisLast Updated:March 7, 2018Completed
Condition(s):Myelodysplastic SyndromesLast Updated:April 13, 2023Suspended
Condition(s):Renal Artery Stenosis; Ischemic Nephropathy; Renovascular Disease; Chronic Kidney DiseaseLast Updated:January 27, 2021Completed
Condition(s):Crohn’s DiseaseLast Updated:April 27, 2017Unknown status
Condition(s):Gingival RecessionLast Updated:June 17, 2020Completed
Condition(s):Spinal Tuberculosis; Mesenchymal Stem CellLast Updated:August 3, 2020Unknown status
Condition(s):ARDSLast Updated:July 18, 2013Unknown status
Condition(s):Covid 19Last Updated:June 4, 2020Unknown status
Condition(s):Ketoacidosis, DiabeticLast Updated:May 5, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.